NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $91,000 | 0.0% | 1,045 | +8.3% | 0.05% | -5.6% |
Q4 2019 | $91,000 | +8.3% | 965 | 0.0% | 0.05% | +5.9% |
Q3 2019 | $84,000 | -9.7% | 965 | 0.0% | 0.05% | -13.6% |
Q1 2019 | $93,000 | +78.8% | 965 | +60.8% | 0.06% | +84.4% |
Q3 2017 | $52,000 | -96.8% | 600 | -96.9% | 0.03% | -97.7% |
Q4 2015 | $1,643,000 | -10.3% | 19,099 | -4.1% | 1.37% | -10.9% |
Q3 2015 | $1,832,000 | -64.3% | 19,925 | -70.4% | 1.54% | -28.7% |
Q2 2015 | $5,128,000 | +104.5% | 67,292 | +164.6% | 2.16% | +3.2% |
Q1 2015 | $2,508,000 | -46.1% | 25,431 | -49.4% | 2.09% | +8.1% |
Q4 2014 | $4,652,000 | +3.0% | 50,212 | +4.7% | 1.94% | -3.5% |
Q3 2014 | $4,516,000 | +145.6% | 47,972 | +136.1% | 2.01% | +19.5% |
Q2 2014 | $1,839,000 | +10.3% | 20,319 | +3.6% | 1.68% | +4.7% |
Q1 2014 | $1,667,000 | +15.6% | 19,609 | +9.3% | 1.60% | +9.0% |
Q4 2013 | $1,442,000 | -44.7% | 17,939 | -47.2% | 1.47% | -5.2% |
Q3 2013 | $2,608,000 | +127.4% | 33,998 | +109.6% | 1.55% | -11.0% |
Q2 2013 | $1,147,000 | – | 16,219 | – | 1.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |